Past Episodes

This week, we're going to hear from 3 experts on very different aspects of COVID-19 and MS. Kathy Costello, the Associate Vice-President of Healthcare Access for the National Multiple Sclerosis Society is going to give us our weekly update on COVID-19 and MS. Mandy Rohrig, a physical therapist who specializes in the rehabilitation of people with Multiple Sclerosis and Parkinson's disease. is going to talk to us about exercises that you can do at home to stay healthy. And then you'll meet Nanc...

This week, and for the foreseeable future, we're committed to sharing the most updated and reliable information on COVID-19 and MS. Returning as my guest on the podcast is Dr. Mitzi Joi Williams. Dr. Williams is a Board-Certified Neurologist and Fellowship trained Multiple Sclerosis Specialist who is passionate about educating and empowering people affected by MS to understand the disease process and the goals of treatment. She is a sought-after consultant, speaker, researcher, and author with ...

This week, and for the foreseeable future, we're committed to sharing the most updated and reliable information on COVID-19 and MS. Joining me as my guest is Dr. Tanuja Chitnis, a board-certified neurologist specializing in multiple sclerosis, with a dual appointment at the Brigham and Women's Hospital and Massachusetts General Hospital in Boston. Dr. Chitnis is a Professor of Neurology at Harvard Medical School and a Senior Scientist at the Ann Romney Center for Neurologic Diseases at Brigham...

This week, and for the foreseeable future, we're committed to sharing the most updated and reliable information on COVID-19 and MS. Joining me as my guest is Dr. Kevin Alschuler, a Rehabilitation Psychologist with appointments as an Associate Professor in the Department of Rehabilitation Medicine and Adjunct Associate Professor in the Department of Neurology at the University of Washington. Dr. Alschuler also serves as the Psychology Director for the UW Medicine Multiple Sclerosis Center. Dr. ...

This week, and for the foreseeable future, we're committed to sharing the most updated reliable information on COVID-19 and MS. Joining me as my guest is Dr. Aaron Miller. Dr. Miller is the Chair of the Society's National Medical Advisory Committee and is also the Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis and a Professor of Neurology at the Icahn School of Medicine at Mount Sinai. He also serves as Vice-Chair for Education in the Department of Neurology. ...

The National MS Society's National Medical Advisory Committee has issued its recommendations for MS disease-modifying therapies and the coronavirus (COVID-19), and we're sharing them in this episode. You'll also hear about a new disease-modifying therapy that's about to receive FDA approval. We'll tell you about a clinical trial for a potential disease-modifying therapy for progressive MS that fell short of achieving its goals. And you'll hear about study results that indicate there are still a...

It's hard to talk to anyone about anything without talking about the coronavirus. And because the CDC has announced that people with weakened immune systems may be particularly vulnerable to this virus, people affected by MS can feel as though they have even more reason to worry. My guest is clinical psychologist Dr. Abbey Hughes and we're talking about how people affected by MS should be thinking about the coronavirus, and what they should and shouldn't be doing about it. You'll also hear abo...

My guest is Dr. Jackie Bhattarai and we're talking about her research exploring the disparities in MS-related depression and fatigue symptoms between African-Americans living with MS and Caucasians living with MS. We're also talking about positive clinical trial results for a drug that slows disability progression in people living with primary progressive MS and non-active secondary progressive MS. And we'll tell you about the new MS drug from Novartis that's awaiting FDA and EMA approval. You...

Welcome to this Bonus Episode of RealTalk MS, coming to you from the 2020 ACTRIMS Forum. ACTRIMS is an acronym for the Americas Committee for Treatment and Research in Multiple Sclerosis. And this year, 1200 MS research scientists and clinicians have come together to share the latest MS research news and insights. We'll take you inside the proceedings at ACTRIMS and share the highlights of some of the most compelling presentations. My first guest is the recipient of this year's Barancik Prize,...

We're just a week away from the National MS Society's Public Policy Conference in Washington, D.C. And my guest is Diane Kramer, an MS Activist from State College, Pennsylvania, who will be attending the Public Policy Conference for the first time. Diane has experienced some of the same obstacles and frustrations that so many people living with MS experience -- insurance companies preventing her from getting the disease-modifying therapy that her neurologist prescribed, having the high cost of ...